Si deseas distinguir tus productos, servicios o ambos de los de otra empresa, es posible que necesites una marca o nombre comercial. Descubre qué son, en qué consiste su procedimiento de registro y qué implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Si tienes un nuevo dispositivo, producto o procedimiento que resuelva un problema técnico o tenga una ventaja práctica, existen distintas formas de protegerlo en España y en otros países. Descubre cómo hacerlo.
¿Tu innovación reside en la estética, la ornamentación o la apariencia de tu producto? Protégela mediante un diseño industrial. Descubre qué derechos confiere el registro y cómo realizar la tramitación.
Las indicaciones geográficas protegen el nombre de un producto originario de una zona geográfica, a la cual le debe una determinada calidad, reputación u otra característica. Descubre qué son, en qué consiste su procedimiento de registro y qué beneficios conceden.
Las patentes publicadas en todo el mundo son una valiosa fuente de información científica, técnica y comercial.
La Oficina de Propiedad Intelectual de la Unión Europea cierra la solicitud de ayuda del Fondo para pymes (SME Fund) hasta la siguiente convocatoria en 2026.
Si eres emprendedor/a o una empresa y quieres potenciar y mejorar la rentabilidad de tu negocio protegiendo de forma adecuada los activos intangibles de tu organización, en este espacio encontrarás lo necesario.
119
resultados
Última actualización
19/12/2025 [06:56:00]
Resultados 100 a 119 de 119
Resumen de: CN223471042U
The utility model discloses an integrated blood glucose collecting and detecting device which comprises a cylindrical shell, a test paper containing bin is arranged on the upper portion of an inner cavity of the shell, a cap is connected to the top of the test paper containing bin, a blood glucose meter host is arranged on the lower portion of the inner cavity of the shell, a blood sampling part is fixedly connected to the bottom of the shell and comprises a round tube, and a baffle is arranged in the round tube. The lower surface of the baffle is fixedly connected with a spring, the bottom of the spring is fixedly connected with an ejection piece, the side face of the ejection piece is fixedly provided with a deflector rod, the outer surface of the round tube is provided with a straight sliding groove matched with the deflector rod for use, the bottom of the ejection piece is fixedly connected with a blood taking needle, the bottom of the round tube is fixedly connected with an adjusting tube, and the bottom of the adjusting tube is fixedly connected with a screwing head. The blood glucose meter main body is arranged in the device, after blood is collected, blood glucose can be directly detected, and therefore the purposes of being convenient to carry and use are achieved.
Resumen de: US2025325229A1
This application discloses a blood glucose management method and a related electronic device. In the method, meal time of a diet event of a user can be determined based on a blood glucose value of the user, and when a blood glucose curve drawn based on blood glucose values of the user is displayed, the meal time and/or a blood glucose value related to the meal time are/is displayed on the blood glucose curve. In this way, the diet event of the user can be associated with blood glucose of the user, and a blood glucose change of the user before and after a meal can be highlighted. This helps the user more intuitively learn of impact of a diet on the blood glucose, and helps the user manage and control the blood glucose starting from the diet.
Resumen de: US2025325580A1
Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
Resumen de: US2025325742A1
An ambulatory infusion pump can include a maximum bolus override procedure. When a bolus amount greater than a maximum bolus amount is requested, the pump can provide an alert indicating that the amount requested exceeds the maximum bolus amount. If the user confirms the request in response to the alert, the bolus amount can be delivered to the user. The amount delivered in response to the confirmation can be a first portion of the bolus amount. A reminder can then be provided that a second portion of the bolus amount that is a remaining portion of the requested bolus amount was also requested. If a second confirmation is received in response to the alert, the second portion of the bolus amount can also delivered to the user.
Resumen de: US2025327768A1
Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.
Resumen de: US2025329432A1
The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
Resumen de: WO2025218117A1
The present application relates to the technical field of medical equipment, and discloses an in-vivo blood glucose monitoring apparatus, comprising a housing, an in-vivo monitoring unit, a sealing film, and a piercing member. An accommodating cavity with a downward-facing cavity opening and an accommodating space located below the accommodating cavity are provided in the housing. The in-vivo monitoring unit comprises a sensor assembly disposed in the accommodating cavity and a transmitter assembly disposed in the accommodating space. The sealing film is disposed at the cavity opening of the accommodating cavity and used for sealing the accommodating cavity. The piercing member is disposed in the accommodating space. A piercing area and a clearance area are provided in a circumferential direction of the piercing member. The piercing member can move relative to the sealing film, enabling the piercing area to pierce the sealing film. Moreover, the pierced sealing film is stored in the accommodating cavity under the action of the clearance area. When the in-vivo blood glucose monitoring apparatus in the present application is used, the user only needs to operate the piercing member and the needle assistance unit, omitting the step of manually assembling the sensor assembly, simplifying the operation steps of the user, and thus improving the use experience of the user.
Resumen de: WO2025221009A1
The present invention relates to a red blood cell blood glucose diagnosis system and method using high-frequency ultrasound, which enable efficient red blood cell blood glucose diagnosis using integrated backscatter (IB) analysis of cell membrane acoustic reflection signals of red blood cells collected using a high-frequency ultrasonic transducer. The red blood cell blood glucose diagnosis system comprises: an ultrasonic diagnosis signal processing unit for setting a diagnosis range and receiving red blood cell reflection signals reflected by applying ultrasonic signals to blood to be diagnosed; and a diagnostic signal analysis and determination unit for processing the reflected signal data received from the ultrasonic diagnostic signal processing unit and outputting glycated hemoglobin quantification and diabetes diagnosis results through integrated backscatter (IB) analysis.
Resumen de: AU2025242195A1
INTERMITTENT MONITORING Various examples are directed to systems and methods for patient monitoring. An example method comprises receiving an estimated glucose concentration level of the patient from a continuous glucose monitoring (CGM) system for a first time period. The method may also include receiving non-glucose information relating to the patient for the first time period and determining a relationship between the estimated glucose concentration level and the non-glucose information. The method may also include receiving non-glucose information relating to the patient for a second time period and determining diabetic information about the patient for the second time period based upon the determined relationship and the non-glucose information. The method may include electronically delivering a notification about the diabetic information. INTERMITTENT MONITORING Various examples are directed to systems and methods for patient monitoring. An example method comprises receiving an estimated glucose concentration level of the patient from a continuous glucose monitoring (CGM) system for a first time period. The method may also include receiving non-glucose information relating to the patient for the first time period and determining a relationship between the estimated glucose concentration level and the non-glucose information. The method may also include receiving non-glucose information relating to the patient for a second time period and determining diabetic information
Resumen de: US2025325230A1
A blood glucose prediction method and device based on optical signal features and metabolic thermal features. The method comprises: acquiring first calibrated blood glucose data (1); collecting and generating first, second, third and fourth optical signals (2); collecting and generating first, second, third, fourth, fifth, sixth and seventh metabolic thermal signals (3); extracting and normalizing human optical signal features to generate first, second and third optical feature data groups (4); extracting and normalizing ambient light signal features to generate fourth optical feature data (5); extracting and normalizing metabolic thermal features to generate first, second, third, fourth, fifth, sixth and seventh metabolic thermal feature data (6); performing feature fusion to generate a first feature vector (7); predicting, on the basis of the floating blood glucose prediction model, floating blood glucose values to generate first floating blood glucose data (8); and generating first predicted blood glucose data according to the sum of the first calibrated blood glucose data and the first floating blood glucose data (9). The blood glucose prediction method and device based on optical signal features and metabolic thermal features can be used to provide a non-invasive blood glucose measurement mechanism.
Resumen de: US2025325182A1
Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection. The method also includes, during the second interval, the analyte sensor system transmitting the encrypted analyte value to the display device, if the determination indicates that the authentication was performed during the first interval.
Resumen de: US2025325201A1
An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.
Resumen de: EP4635406A2
The present invention relates to a continuous blood glucose measurement device which is produced with an assembled body attachment unit inside an applicator so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body by simply activating the applicator, and, particularly, the present invention provides a continuous blood glucose measurement device which: is provided with a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use, without additional work of connecting a separate transmitter, and easier maintenance; and is activated by the user after the body attachment unit is attached to the body so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.
Resumen de: EP4635409A2
The present disclosure relates to a method for stabilizing a continuous glucose monitoring system. The method for stabilizing a continuous glucose monitoring system according to an embodiment of the present invention may comprise: a step of measuring biometric information by a sensor transmitter disposed in a part of a user's body so as to measure the user's biometric information; a step of transmitting, by the sensor transmitter, data on the measured biometric information (biometric information data) to a communication terminal; a stabilization step of stabilizing, by the communication terminal, the biometric information data received from the sensor transmitter; and a step of displaying, by the communication terminal, the biometric information data after the stabilizing step is completed, so as to allow the user to identify the biometric information data received from the sensor transmitter, wherein in the stabilization step, the communication terminal variably controls the time during which the biometric information data received from the sensor transmitter is stabilized. The present disclosure has an advantage in that the time during which data measured by a sensor transmitter is stabilized can be variably controlled according to sensor transmitters, and thus accurate biometric information data can be provided to a user.
Resumen de: EP4635416A2
The present invention relates to a sensor applicator assembly for a continuous glucose monitoring system and provides a sensor applicator assembly for a continuous glucose monitoring system, which is manufactured with a sensor module assembled inside an applicator, thereby minimizing additional work by a user for attaching the sensor module to the body and allowing the sensor module to be attached to the body simply by operating the applicator, and thus can be used more conveniently. A battery is built in the sensor module and a separate transmitter is connected to the sensor module so as to receive power supply from the sensor module and be continuously used semi-permanently, thereby making the assembly economical. The sensor module and the applicator are used as disposables, thereby allowing accurate and safe use and convenient maintenance.
Resumen de: CN120823990A
The invention relates to the technical field of medicine, discloses a medical detection method, and particularly relates to a myocardial state detection method and system for a diabetic patient. Through combination of multiple groups of indexes and image group characteristic data, the cardiovascular disease, especially the cardiovascular disease of a diabetic patient, can be effectively evaluated, and score data reflecting the myocardial state of the diabetic patient can be obtained. And the incidence probability and the staging result degree of the myocardial disease of the diabetic patient are more intuitively determined through the score data, so that the overall automatic prediction of the incidence of the myocardial disease of the diabetic patient is realized.
Resumen de: CN120825675A
The invention discloses a blood glucose management system which is characterized in that when a patient operates and establishes communication connection, at least one of a detection module, an infusion module and a program module serves as signal source equipment to send low-power broadcast signals, and at least one of the equipment serves as equipment to be paired and establish communication connection; a patient operates the to-be-paired communication connection establishment device to approach the signal source device, when the to-be-paired communication connection establishment device enters the effective range of the broadcast signal, the broadcast signal can be searched, and the to-be-paired communication connection establishment device is paired with the signal source device to establish communication connection; the range is generally smaller than the conventional distance between the two devices, the situation that wrong communication connection is established due to the fact that the to-be-paired communication connection establishing device searches wrong broadcast signals can be avoided, a patient can automatically establish communication connection with the signal source device without inputting a device code, time and labor are saved, and the patient experience is improved. And the use experience of the patient is improved.
Resumen de: CN223453554U
The utility model provides a fixed application for an insulin pump, which relates to the technical field of medical instruments, and comprises an application, the application is used for fixing an infusion needle of the insulin pump, the infusion needle penetrates through the middle position in the application, one side of the infusion needle is connected with an infusion catheter, and the other side of the infusion needle is connected with an infusion tube. A fastening adhesive tape is arranged on the outer surface of the infusion catheter, and the fastening adhesive tape is used for fixing the infusion catheter; through the arrangement of the application and the fastening adhesive tape, the infusion needle head can be firmly fixed in the insulin pump, the fixing effect and the wearing comfort of the insulin pump are effectively improved, adverse effects of skin are reduced, and a better guarantee is provided for a patient to use the insulin pump.
Nº publicación: CN223453322U 21/10/2025
Solicitante:
GENERAL HOSPITAL OF EASTERN THEATER COMMAND OF THE CHINESE PEOPLES LIBERATION ARMY
\u4E2D\u56FD\u4EBA\u6C11\u89E3\u653E\u519B\u4E1C\u90E8\u6218\u533A\u603B\u533B\u9662
Resumen de: CN223453322U
The utility model discloses a blood glucose detection disc, and relates to the technical field of medical instruments. The blood glucose detection disc comprises a storage structure, a storage structure is arranged at the top end of the storage structure, a top cover is arranged at the top end of the storage structure, the storage structure comprises a storage disc, two placement cavities are formed in the storage disc, and a mounting frame is placed in the placement cavity on the rear side. According to the blood glucose detection disc, a storage structure is arranged, a plurality of storage discs and a plurality of trays can be placed in two placement cavities in the storage disc, and matched clamping can be performed according to the size of a medical tool in cooperation with grids, fixing rings and buffer arc plates in the trays; the medical tools of different specifications can be placed on the storage disc and the tray, so that the medical tools can be separated while being placed, the medical tools can be placed in the storage disc and the tray in order as far as possible, and the medical tools can be stably placed.
BOPI
Sede Electrónica
